drugset / Trial / NCT00352417
Study Effect of VIA-2291 on Atherosclerotic Vascular Inflammation in Patients Undergoing Elective Carotid Endarterectomy
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a study to compare the effect of VIA-2291 vs. Placebo on various inflammatory biomarkers in patients with carotid stenosis scheduled for elective carotid endarterectomy
Timeline
- Start
- 2006-07
- Primary completion
- 2008-07
- Completion
- 2008-07
Outcome
Missed primary endpoint
registry analysis (superiority or other test); VIA-2291 vs Matching Placebo; p = 0.97; t-test, 2 sided NCT00352417 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ATRELEUTON | Small molecule | 100 mg | Oral |